Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi Lepri

Showing results (141-150 of 227) with videos related to

Pageof 23
Sort By:
International Journal of Molecular Sciences|May 7, 2025
Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster VaccineAlessandra Vergori, Giulia Matusali, Eleonora Cimini, et al.
BMC Infectious Diseases|September 6, 2013
The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control studyAndrea De Luca, Katleen de Gaetano Donati, Manuela Colafigli, et al.
AIDS (London, England)|October 17, 2018
The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapyAnna Schultze, Carlo Torti, Alessandro Cozzi-Lepri, et al.
Plos One|December 7, 2013
The potential of antimicrobials to induce thrombocytopenia in critically ill patients: data from a randomized controlled trialMaria Egede Johansen, Jens-Ulrik Jensen, Morten Heiberg Bestle, et al.
Journal of Global Antimicrobial Resistance|July 15, 2023
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohortAdriana Cervo, Antonio Russo, Domenico Di Carlo, et al.
Human Vaccines & Immunotherapeutics|November 6, 2025
Determinants of non-compliance with additional booster doses of the SARS-CoV-2 vaccine in people living with HIV (PWH): An observational study based on a behavioral and epidemiological survey in Rome (Italy)Giulia Del Duca, Isabella Sperduti, Alessandro Cozzi Lepri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failuresMaria Paola Trotta, Alessandro Cozzi-Lepri, Adriana Ammassari, et al.
Plos One|October 24, 2017
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling studyMikaela Smit, Rachel Cassidy, Alessandro Cozzi-Lepri, et al.
HIV Clinical Trials|August 22, 2014
Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohortAntonio Di Biagio, Laura Ambra Nicolini, Patrizia Lorenzini, et al.
Antiviral Therapy|May 12, 2004
Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAARTAndrea Antinori, Alessandro Cozzi-Lepri, Adriana Ammassari, et al.
Pageof 23

Showing results (141-150 of 227) with videos related to

Sort By:
Pageof 23
International Journal of Molecular Sciences|May 7, 2025
Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster VaccineAlessandra Vergori, Giulia Matusali, Eleonora Cimini, et al.
BMC Infectious Diseases|September 6, 2013
The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control studyAndrea De Luca, Katleen de Gaetano Donati, Manuela Colafigli, et al.
AIDS (London, England)|October 17, 2018
The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapyAnna Schultze, Carlo Torti, Alessandro Cozzi-Lepri, et al.
Plos One|December 7, 2013
The potential of antimicrobials to induce thrombocytopenia in critically ill patients: data from a randomized controlled trialMaria Egede Johansen, Jens-Ulrik Jensen, Morten Heiberg Bestle, et al.
Journal of Global Antimicrobial Resistance|July 15, 2023
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohortAdriana Cervo, Antonio Russo, Domenico Di Carlo, et al.
Human Vaccines & Immunotherapeutics|November 6, 2025
Determinants of non-compliance with additional booster doses of the SARS-CoV-2 vaccine in people living with HIV (PWH): An observational study based on a behavioral and epidemiological survey in Rome (Italy)Giulia Del Duca, Isabella Sperduti, Alessandro Cozzi Lepri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failuresMaria Paola Trotta, Alessandro Cozzi-Lepri, Adriana Ammassari, et al.
Plos One|October 24, 2017
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling studyMikaela Smit, Rachel Cassidy, Alessandro Cozzi-Lepri, et al.
HIV Clinical Trials|August 22, 2014
Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohortAntonio Di Biagio, Laura Ambra Nicolini, Patrizia Lorenzini, et al.
Antiviral Therapy|May 12, 2004
Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAARTAndrea Antinori, Alessandro Cozzi-Lepri, Adriana Ammassari, et al.
Pageof 23